The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Transcriptomic signatures of MSI-high metastatic colorectal cancer to predict efficacy of immune checkpoint inhibitors.
 
Claire Gallois
Consulting or Advisory Role - SERVIER
Travel, Accommodations, Expenses - Amgen
 
Matteo Landi
No Relationships to Disclose
 
Julien Taieb
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Merck KGaA; MSD; Novartis; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; Merck; MSD; Pierre Fabre; SERVIER
 
Sara Lonardi
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Incyte; Lilly; Merck Serono; Mirati Therapeutics; MSD; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)
 
Francesca Bergamo
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; SERVIER
Speakers' Bureau - Bayer; Eisai; Lilly; MSD Oncology
 
Rossana Intini
No Relationships to Disclose
 
Giulia Maddalena
No Relationships to Disclose
 
Filippo Pietrantonio
Honoraria - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Pierre Fabre; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Merck; Merck Serono; Merck Serono; MSD Oncology; SERVIER
Research Funding - Astrazeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst)
Travel, Accommodations, Expenses - Pierre Fabre; Pierre Fabre
 
Francesca Corti
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Ipsen
 
Margherita Ambrosini
No Relationships to Disclose
 
Antonia Martinetti
No Relationships to Disclose
 
Marco Maria Germani
No Relationships to Disclose
 
Chiara Boccaccio
No Relationships to Disclose
 
Guglielmo Vetere
No Relationships to Disclose
 
Sophie Mouillet-Richard
No Relationships to Disclose
 
Aurélien de Reynies
No Relationships to Disclose
 
Pierre Laurent Puig
Stock and Other Ownership Interests - Methys
Honoraria - Amgen; AstraZeneca; BIOCARTIS; Merck; MSD Oncology; Roche; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Patents, Royalties, Other Intellectual Property - Inventor of mir31-3p licence to integragen
Travel, Accommodations, Expenses - Merck; Roche
 
Chiara Cremolini
Honoraria - Amgen; Bayer; Merck; Merck; MSD; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bayer; MSD; Nordic Bioscience; Pierre Fabre; Roche
Speakers' Bureau - Merck; Pierre Fabre; SERVIER
Research Funding - Bayer; Merck; Roche; SERVIER